Evidence map›Paper›PMID 16504375›Full record

ArticleMolecular and cellular endocrinology2006

TGF-β1 regulation of human AT1 receptor mRNA splice variants harboring exon 2.

Mickey M Martin, Jessica A Buckenberger, Daren L Knoell, Arthur R Strauch, Terry S Elton

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Molecular and cellular endocrinology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mickey M MartinCollege of Pharmacy, Division of Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Jessica A Buckenberger
Daren L Knoell
Arthur R Strauch
Terry S Elton
The Ohio State University · USLung Institute · US

Funding

Myofibroblasts and fibrosis after cardiac transplantP01HL070294 · NHLBI · OHIO STATE UNIVERSITY · PI STRAUCH, ARTHUR ROGER · 2001 to 2005
$6.3M
HUMAN ANGIOTENSIN II RECEPTOR GENE REGULATIONR01HL048848 · NHLBI · OHIO STATE UNIVERSITY · PI ELTON, TERRY S · 1997 to 2009
$2.1M
ANGIOTENSIN II RECEPTOR GENE EXPRESSIONR29HL048848 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELTON, TERRY S · 1992 to 1996
–
NHLBI NIH HHS HL48848NHLBI NIH HHS HL70294
6 · The paper itself

Abstract

At least four alternatively spliced mRNAs can be synthesized from the human AT(1)R (hAT(1)R) gene that differ only in the inclusion or exclusion of exon 2 and/or 3. RT-PCR experiments demonstrate that splice variants harboring exon 2 accounts for at least 30% of all the hAT(1)R mRNA transcripts expressed in the human tissues investigated. Since exon 2 contains two upstream AUGs or open reading frames (uORFs), we hypothesized that these AUGs would inhibit the translation of the downstream hAT(1)R protein ORF harbored in exon 4. This study demonstrates that the inclusion of exon 2 in hAT(1)R mRNA transcripts dramatically reduces hAT(1)R protein levels (nine-fold) and significantly attenuates Ang II responsiveness ( approximately four-fold). Interestingly, only when both AUGs were mutated in combination were the hAT(1)R density and Ang II signaling levels comparable with those values obtained using mRNA splice variants that did not include exon 2. This observation is consistent with a model where the majority of the ribosomes likely translate uORF#1 and are then unable to reinitiate at the downstream hAT(1)R ORF, in part due to the presence of AUG#2 and to the short intercistronic spacing. Importantly, TGF-beta(1) treatment (4ng/ml for 4h) of fibroblasts up-regulated hAT(1)R mRNA splice variants, which harbored exon 2, six-fold. Since AT(1)R activation is closely associated with cardiovascular disease, the inclusion of exon 2 by alternative splicing represents a novel mechanism to reduce the overall production of the hAT(1)R protein and possibly limit the potential pathological effects of AT(1)R activation.

Indexed as

Alternative SplicingUp-RegulationBase SequenceCodon, InitiatorExonsHumansMolecular Sequence DataReceptor, Angiotensin, Type 1RNA, MessengerSequence AlignmentTransforming Growth Factor betaCodon, InitiatorReceptor, Angiotensin, Type 1RNA, MessengerTransforming Growth Factor beta

Identifiers

PMID16504375
OpenAlexW1987986239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.